AI safety and research company Anthropic has announced a new partnership with the Gates Foundation, committing $200 million over the next four years to support initiatives in global health, life sciences, education, and economic mobility. The commitment includes grant funding, Claude AI usage credits, and technical support for programmes across the US and several international markets.
The collaboration will primarily focus on improving healthcare outcomes in low- and middle-income countries, where billions of people continue to lack access to essential medical services. Anthropic and the Gates Foundation plan to accelerate vaccine and therapy development while helping governments strengthen health intelligence systems for better decision-making in areas such as workforce deployment, outbreak detection, and supply chain management.
As part of the initiative, Anthropic will develop AI connectors, healthcare benchmarks, and evaluation frameworks to improve how researchers, governments, and healthcare providers assess AI performance in medical applications. The partnership will also explore the use of Claude AI to support frontline healthcare workers and patients in diagnosis and treatment navigation.
The programme will additionally support research into neglected and high-burden diseases, including polio, HPV, and preeclampsia. Scientists will use Claude to analyse large datasets, identify vaccine and drug candidates, and shorten early-stage research timelines.
Beyond healthcare, the partnership will support AI-powered education tools for K-12 students in the US, India, and sub-Saharan Africa. Anthropic and the Gates Foundation will also develop public datasets and benchmarks for AI-driven tutoring, literacy, numeracy, and career guidance applications.
In the economic mobility sector, the collaboration aims to improve agricultural productivity for smallholder farmers and develop AI tools that support workforce training, career guidance, and employment outcome tracking. Anthropic said the initiative reflects its broader goal of ensuring AI benefits extend to sectors where market-driven innovation alone may not reach.
